Clinical Trials
2 trialsNCT06305962 2026-02-19
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT05368506 2023-05-06
ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn